10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

10x Genomics (Nasdaq: TXG) announced that members of its management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. Pacific Time.

Investors and interested parties can watch a live webcast of the fireside chat via the company's Investors website at https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.

Key Figures

Conference date January 12, 2026 J.P. Morgan Healthcare Conference presentation date

Start time 8:15 a.m. Pacific Time Scheduled time for conference fireside chat

Webcast replay period 30 days Archived webcast availability after the event

Market Reality Check

$16.62 Last Close

Volume Volume 891,622 is below the 20-day average of 1,995,310, indicating muted trading ahead of the conference. low

Technical Shares at $16.49 are above the 200-day MA of $12.23 but still 18.93% below the 52-week high of $20.34.

Peers on Argus

TXG fell 1.2% while peers were mixed: OMCL and PHR rose, CERT was flat, and SDGR and GDRX edged lower, suggesting stock-specific dynamics rather than a broad sector move.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 18	Research consortium	Positive	-0.9%	Launch of ASTRA alliance to build pan-cancer spatial atlas using Xenium.
Nov 11	Conference participation	Neutral	+0.6%	Management fireside chat at Wolfe Research Healthcare Conference 2025.
Nov 06	Quarterly earnings	Neutral	-3.6%	Q3 2025 results with $149M revenue and narrowed operating and net losses.
Oct 29	Product launch	Positive	-3.3%	Next-generation Chromium Flex launch to scale single cell research throughput.
Oct 20	AI partnership	Positive	+11.1%	Collaboration with Anthropic to integrate tools into Claude for Life Sciences.

Pattern Detected

Positive strategic and product news has produced mixed reactions, with two recent positive announcements followed by declines and one AI-focused partnership seeing a strong gain.

Recent Company History

Over the last few months, TXG has reported several milestones. An AI-focused collaboration with Anthropic on Oct 20, 2025 saw a 11.07% move, while the new Chromium Flex launch on Oct 29, 2025 and the ASTRA cancer atlas consortium on Nov 18, 2025 were followed by modest declines. Q3 2025 earnings on Nov 6, 2025 showed revenue of $149.0M and a $27.5M net loss. Today’s conference appearance fits into a pattern of ongoing visibility efforts through investor and industry events.

Market Pulse Summary

This announcement highlights TXG’s participation in the high-profile J.P. Morgan Healthcare Conference on January 12, 2026, with a webcast available for at least 30 days. It follows recent product, partnership, and earnings updates, including Q3 2025 revenue of $149.0M and a net loss of $27.5M. Investors may track how management frames growth initiatives, capital allocation, and adoption of key platforms in this forum.

Key Terms

spatial biology medical

"a leader in single cell and spatial biology, announced today that members"

Spatial biology maps where different cells and molecules sit inside tissues, like a detailed city map showing not just who lives in a neighborhood but where every house and shop is located. For investors, those location details can reveal how diseases start and respond to treatments, guiding new drugs, diagnostics, and lab tools that can change clinical success rates and create commercial opportunities.

AI-generated analysis. Not financial advice.

PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 44^th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. Pacific Time.

Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube. 

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts

Investors: investors@10xgenomics.com

Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302650016.html

SOURCE 10x Genomics, Inc.

FAQ

When will 10x Genomics (TXG) present at the J.P. Morgan Healthcare Conference?

10x Genomics will present on January 12, 2026 at 8:15 a.m. Pacific Time.

Where can investors watch the 10x Genomics (TXG) webcast for the January 12, 2026 presentation?

The live webcast will be available on the company's Investors website at https://investors.10xgenomics.com/.

How long will the 10x Genomics (TXG) J.P. Morgan webcast be available for replay?

The webcast will be archived and available for replay for at least 30 days after the event.

What topics will 10x Genomics (TXG) management cover at the January 12, 2026 fireside chat?

The announcement states management will present and hold a fireside chat; no specific topics or financial guidance were provided.

Will the 10x Genomics (TXG) presentation at J.P. Morgan include a Q&A for investors?

The release describes a fireside chat presentation; it does not specify whether a live Q&A will be included.